Clinical Trial Update: Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial is evaluating a DPP-4 inhibitor for cisplatin-induced acute kidney injury in cancer patients, spanning Phase 2 and Phase 3, with the current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Kidney Injury

Drugs mentioned

• DPP-4 inhibitor

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Cancer, Cisplatin Adverse Reaction | Phase 2, Phase 3 | Status: UNKNOWN